Vatera Healthcare Partners

by in

Entry	Author	Date	Location
Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing	Catherine Arnst	11/29/12	Boston
Rib-X Pharmaceuticals Lands Series B Financing Round	VentureDeal	11/29/12	Boston
Pearl Therapeutics Secures $65,000,000 Series D Round	VentureDeal	11/13/12	San Francisco
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers	Erin Kutz	12/16/11	Boston
Kinvey, Zink, ImmusanT, and More of this Week’s Boston Dealmakers	Erin Kutz	12/14/11	Boston
ImmusanT, Developing Celiac Disease Treatments, Closes $20M Series A	Erin Kutz	12/13/11	Boston
ImmusanT Secures $20,000,000 Series A Round	VentureDeal	12/13/11	Boston
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial	Luke Timmerman	12/01/10	San Francisco
Exelixis Seeks to Exit Doghouse, Sangamo Morphs Into Drugmaker, Siluria Adds $13M, & More Bay Area Life Sciences News	Luke Timmerman	10/22/10	San Francisco
Pearl Therapeutics Gets $69M	Luke Timmerman	10/19/10	San Francisco
Pearl Therapeutics Receives $69,000,000 Series C Financing Round	VentureDeal	10/19/10	San Francisco
Page 1 of 1

Xconomy National